Video Buzz v1
Highlighting streaming videos you should be watching
RelatedLinks
June 30th
- YouTube - Dr. Robert Rowen, MD Vitamic C Amazing Healing Benefits: Dr. says never seen any kidney stones form from Vita-C
- YouTube - Intravenous Vitamin C for Cancer Cure on ABC News
June 21st
- PSEUDOMONAS ENDOCARDITIS IN INTRAVENOUS DRUG USERS: Pseudomonas aeruginosa is a very common cause of endocarditis,s pecially in intravenous drug users.It has the capacity to infect native as well as prosthetic heart valves.The source of this bacteria is usually the standing water contaminating drug
June 18th
- Trimester of Pregnancy: ... The physician should look for other pathologic causes of the vomiting such as gastroenteriti s, hepatitis, ulcer, or disorders of the gall bladder, kidney, or pancreas. For some women, the condition returns in subsequent pregnancies. At the least, ...
April 28th
April 25th
March 28th
February 27th
- Intravenous vitamin C as a chemotherapy agent: a r...[P R Health Sci J. 2004] - PubMed Result: Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.\ ;nRiordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massar i JR, Rosario N, Rivera A.\nP R Health Sci J. 2004 Jun
- Intravenously administered vitamin C as cancer therapy: three cases. - CMAJ. 2006 Mar 28: Intravenously administered vitamin C as cancer therapy: three cases.\ ;nPadayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M.\nCM AJ. 2006 Mar 28
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. - Ann Oncol. 2008 Nov: Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Hoffer LJ, Levine M, Assouline S, Melnychuk D, Padayatty SJ, Rosadiuk K, Rousseau C, Robitaille L, Miller WH Jr. Ann Oncol. 2008 Nov
- Vitamin C and cancer revisited ? PNAS: Vitamin C and cancer revisited. Frei B, Lawson S. Proc Natl Acad Sci U S A. 2008 Aug 12
February 8th
January 23rd
December 11th
December 9th
- Competitor - BMS - Erbitux - Cetuximab - Price - ImClone - Bristol Myers Squibb - Merck KGaA - Cetuximab - Wikipedia - $30,000 for 8 weeks intravenous treatment: Cetuximab (IMC-C225 -- marketed under the name Erbitux) is a chimeric monoclonal antibody, an epidermal growth factor receptor (EGFR) inhibitor, given by intravenous injection for treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab was discovered by ImClone Systems and is distributed in North America by ImClone and Bristol-Myers Squibb, while in the rest of the world distribution is by Merck KGaA. Cetuximab costs up to $30,000 for eight weeks of treatment per patient. Chemical data Formula C6484H10042N17 32O2023S36 Mol. mass 145781.6 g/mol
RelatedImages
Video Buzz > Intravenous
No Matching Video
No video for Intravenous is available at this time.
Related Intravenous News
Busch needs treatment following Grand-Am race - Seattle Times
An overheated Kyle Busch received intravenous fluids Saturday following his driving stint in the Grand-Am race, then retreated to his motorhome to rest before NASCAR's 400-mile Sprint Cup event. Busch, the defending race winner of NASCAR's Coke Zero ...
How Medicated Was Michael Jackson? - Time
Citing a single, unnamed law-enforcement source, the Associated Press made the Diprivan claim on Friday. Diprivan, also known as Propofol, is typically used in hospital operating theaters as an intravenous anesthetic. Watch TIME Video: Appreciating ...
Michael Jackson ?Was Hooked to an Intravenous Drip in The 90s? - Showbizspy.com
Michael Jackson ?s addiction to prescription drugs goes as far back as the 90s ? when he was ?regularly hooked to an intravenous drip.? Jackson died Thursday (June 25) after suffering an apparent cardiac arrest at his home in Los Angeles. An ...
Busch overheats, needs treatment - ESPN.com
DAYTONA BEACH, Fla. -- An overheated Kyle Busch received intravenous fluids Saturday following his driving stint in the Grand Am race, then retreated to his motorhome to rest before NASCAR's 400-mile Sprint Cup event. Busch, the defending race winner ...
Busch receives IV treatment following driving stint in Grand-Am race - Hampton Roads Daily Press
DAYTONA BEACH, Fla. (AP) ? Kyle Busch has received intravenous fluids following a 70-minute driving stint in the Grand-Am race at Daytona International Speedway . Busch was co-driving with fellow NASCAR driver Scott Speed in the Saturday afternoon ...
Intravenous Podcasts
Do you prefer to listen to your intravenous gossip? Check out Podzy Podcast Directory > Intravenous.
Intravenous Products
Looking for intravenous related products, then look no further. Try our new Intravenous Shop.